• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Great Strides Made In Developing New Medicines For Cancer


While there has been a great deal of discussion around Obamacare and the Supreme Court ruling that is expected to be announced in the near future, much progress has been made in other areas of public health that has gone largely unnoticed.

A report released earlier this month found that there are 981 medicines and vaccines currently being tested by America’s biopharmaceutical research companies to fight the various types of cancer affecting millions of patients around the world. The potential medicines, which are either in clinical trials or under review by the FDA, include 121 for lung cancer, 117 for lymphoma and 111 for breast cancer.

Read the full story: http://tinyurl.com/7x89x7f

Source: Forbes

Related Videos
Amitkumar Mehta, MD, MBA
dr amy laughlin
dr kathi mooney
dr saira jan
dr saira jan
Ted Okon, MBA, Community Oncology Alliance
Miriam J. Atkins, MD, FACP, Community Oncology Alliance/AO Multispecialty Clinic
Lalan Wilfongd, MD, US Oncology Network
Alma Habib, MD
Related Content
© 2023 MJH Life Sciences
All rights reserved.